About a year ago, Anna DeLaRosby, PT, DPT, had a question for her former classmates from physical therapy school. A 2008 graduate of Clarke University, she had gone on to work at several different clinics and to become a physical therapy instructor herself.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Weighty Matters: Physical Therapy and GLP-1 Medications
What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.
Date: Friday, August 1, 2025
Author:
Chris Hayhurst
Share This
Resource Details
Date: August 1, 2025
Contact: aptamag@apta.org
Content Type: Feature
Topics
Author(s)
Chris Hayhurst
You Might Also Like...
Feature
In the Ring: Supporting Athletes in Combat SportsOct 1, 2025
Combat sports push athletes — and PTs — to their limits. Learn how PTs apply evidence-based care in unpredictable, high-risk environments.
Column
Defining Moment | From Nonclinical to Clinical and Back AgainOct 1, 2025
One PT reflects on a career shaped by unexpected turns, personal discovery, and the enduring impact of patient care.
Success Story
Success Story | From Data to Action: Reducing Hold Status OverutilizationOct 1, 2025
Examining hold status uncovered planning gaps, leading to better communication and outcomes for one organization.